Home / Inspections / 554278

FDA Inspection 554278 — Fresenius Kabi Oncology Limited

Fresenius Kabi Oncology Limited — FEI 3006210232

The FDA completed an inspection of Fresenius Kabi Oncology Limited on November 20, 2008 in Baddi. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 20, 2008
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Baddi (India)

Facility

Other inspections at this facility

  • 1220476 (OAI Tue Oct 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1010068 (OAI Fri Apr 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 927828 (OAI Fri May 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 800493 (VAI Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 636945 (VAI Fri Nov 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources